Following treatment with salidroside at 80 μM (at this dose, the cell viability is more than 60%), the levels of PKM2, GLUT1, and enolase 1 (ENO1) in SGC-7901 and MKN-45 gastric cancer cells decrease markedly, and glycolysis is inhibited. This evidence concerns the gene SLC2A1 and gastric cancer.